Selected research
Market Structure
Global Quetiapine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Quetiapine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Quetiapine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Quetiapine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Quetiapine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Quetiapine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Quetiapine include XiaoGan ShenYuan ChemPharm, Teva, Sun Pharmaceutical, Sandoz, Qilu Pharmaceutical, Nanjing Sunlida Biological Technology, Mylan, Lupin and Hetero, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Quetiapine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Quetiapine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Quetiapine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Quetiapine market size, projected growth trends, production technologies, key applications, and end-use industries.
Quetiapine Segment by Company
XiaoGan ShenYuan ChemPharm
Teva
Sun Pharmaceutical
Sandoz
Qilu Pharmaceutical
Nanjing Sunlida Biological Technology
Mylan
Lupin
Hetero
Shanghai Haoyuan Chemexpress
Dr. Reddy's
Aurobindo
AstraZeneca
Wuhan Fortuna Chemical
Waterstone Technology
Toronto Research Chemicals
Nanjing Chemlin Chemical
EMMX Biotechnology
BOC Sciences
AlliChem
Quetiapine Segment by Type
Purity 97%
Purity 98%
Others
Quetiapine Segment by Application
Adult
Aged
Quetiapine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Quetiapine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Quetiapine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Quetiapine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Quetiapine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Quetiapine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Quetiapine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Quetiapine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Purity 97%
- Purity 98%
- Others
Applications
- Adult
- Aged
Companies covered
- XiaoGan ShenYuan ChemPharm
- Teva
- Sun Pharmaceutical
- Sandoz
- Qilu Pharmaceutical
- Nanjing Sunlida Biological Technology
- Mylan
- Lupin
- Hetero
- Shanghai Haoyuan Chemexpress
- Dr. Reddy's
- Aurobindo
- AstraZeneca
- Wuhan Fortuna Chemical
- Waterstone Technology
- Toronto Research Chemicals
- Nanjing Chemlin Chemical
- EMMX Biotechnology
- BOC Sciences
- AlliChem
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Quetiapine Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Quetiapine Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Quetiapine Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Quetiapine Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Quetiapine Market Dynamics
- 2.1 Quetiapine Industry Trends
- 2.2 Quetiapine Industry Drivers
- 2.3 Quetiapine Industry Opportunities and Challenges
- 2.4 Quetiapine Industry Restraints
3 Quetiapine Market by Manufacturers
- 3.1 Global Quetiapine Revenue by Manufacturers (2021-2026)
- 3.2 Global Quetiapine Sales by Manufacturers (2021-2026)
- 3.3 Global Quetiapine Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Quetiapine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Quetiapine Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Quetiapine Manufacturers, Product Type & Application
- 3.7 Global Quetiapine Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Quetiapine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Quetiapine Players Market Share by Revenue in 2025
- 3.8.3 2025 Quetiapine Tier 1, Tier 2, and Tier 3
4 Quetiapine Market by Type
- 4.1 Quetiapine Type Introduction
- 4.1.1 Purity 97%
- 4.1.2 Purity 98%
- 4.1.3 Others
- 4.2 Global Quetiapine Sales by Type
- 4.2.1 Global Quetiapine Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Quetiapine Sales by Type (2021-2032)
- 4.2.3 Global Quetiapine Sales Market Share by Type (2021-2032)
- 4.3 Global Quetiapine Revenue by Type
- 4.3.1 Global Quetiapine Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Quetiapine Revenue by Type (2021-2032)
- 4.3.3 Global Quetiapine Revenue Market Share by Type (2021-2032)
5 Quetiapine Market by Application
- 5.1 Quetiapine Application Introduction
- 5.1.1 Adult
- 5.1.2 Aged
- 5.2 Global Quetiapine Sales by Application
- 5.2.1 Global Quetiapine Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Quetiapine Sales by Application (2021-2032)
- 5.2.3 Global Quetiapine Sales Market Share by Application (2021-2032)
- 5.3 Global Quetiapine Revenue by Application
- 5.3.1 Global Quetiapine Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Quetiapine Revenue by Application (2021-2032)
- 5.3.3 Global Quetiapine Revenue Market Share by Application (2021-2032)
6 Global Quetiapine Sales by Region
- 6.1 Global Quetiapine Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Quetiapine Sales by Region (2021-2032)
- 6.2.1 Global Quetiapine Sales by Region (2021-2026)
- 6.2.2 Global Quetiapine Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Quetiapine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Quetiapine Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Quetiapine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Quetiapine Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Quetiapine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Quetiapine Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Quetiapine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Quetiapine Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Quetiapine Revenue by Region
- 7.1 Global Quetiapine Revenue by Region
- 7.1.1 Global Quetiapine Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Quetiapine Revenue by Region (2021-2026)
- 7.1.3 Global Quetiapine Revenue by Region (2027-2032)
- 7.1.4 Global Quetiapine Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Quetiapine Revenue (2021-2032)
- 7.2.2 North America Quetiapine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Quetiapine Revenue (2021-2032)
- 7.3.2 Europe Quetiapine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Quetiapine Revenue (2021-2032)
- 7.4.2 Asia-Pacific Quetiapine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Quetiapine Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Quetiapine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 XiaoGan ShenYuan ChemPharm
- 8.1.1 XiaoGan ShenYuan ChemPharm Company Information
- 8.1.2 XiaoGan ShenYuan ChemPharm Business Overview
- 8.1.3 XiaoGan ShenYuan ChemPharm Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 XiaoGan ShenYuan ChemPharm Quetiapine Product Portfolio
- 8.1.5 XiaoGan ShenYuan ChemPharm Recent Developments
- 8.2 Teva
- 8.2.1 Teva Company Information
- 8.2.2 Teva Business Overview
- 8.2.3 Teva Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Teva Quetiapine Product Portfolio
- 8.2.5 Teva Recent Developments
- 8.3 Sun Pharmaceutical
- 8.3.1 Sun Pharmaceutical Company Information
- 8.3.2 Sun Pharmaceutical Business Overview
- 8.3.3 Sun Pharmaceutical Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Sun Pharmaceutical Quetiapine Product Portfolio
- 8.3.5 Sun Pharmaceutical Recent Developments
- 8.4 Sandoz
- 8.4.1 Sandoz Company Information
- 8.4.2 Sandoz Business Overview
- 8.4.3 Sandoz Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Sandoz Quetiapine Product Portfolio
- 8.4.5 Sandoz Recent Developments
- 8.5 Qilu Pharmaceutical
- 8.5.1 Qilu Pharmaceutical Company Information
- 8.5.2 Qilu Pharmaceutical Business Overview
- 8.5.3 Qilu Pharmaceutical Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Qilu Pharmaceutical Quetiapine Product Portfolio
- 8.5.5 Qilu Pharmaceutical Recent Developments
- 8.6 Nanjing Sunlida Biological Technology
- 8.6.1 Nanjing Sunlida Biological Technology Company Information
- 8.6.2 Nanjing Sunlida Biological Technology Business Overview
- 8.6.3 Nanjing Sunlida Biological Technology Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Nanjing Sunlida Biological Technology Quetiapine Product Portfolio
- 8.6.5 Nanjing Sunlida Biological Technology Recent Developments
- 8.7 Mylan
- 8.7.1 Mylan Company Information
- 8.7.2 Mylan Business Overview
- 8.7.3 Mylan Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Mylan Quetiapine Product Portfolio
- 8.7.5 Mylan Recent Developments
- 8.8 Lupin
- 8.8.1 Lupin Company Information
- 8.8.2 Lupin Business Overview
- 8.8.3 Lupin Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Lupin Quetiapine Product Portfolio
- 8.8.5 Lupin Recent Developments
- 8.9 Hetero
- 8.9.1 Hetero Company Information
- 8.9.2 Hetero Business Overview
- 8.9.3 Hetero Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Hetero Quetiapine Product Portfolio
- 8.9.5 Hetero Recent Developments
- 8.10 Shanghai Haoyuan Chemexpress
- 8.10.1 Shanghai Haoyuan Chemexpress Company Information
- 8.10.2 Shanghai Haoyuan Chemexpress Business Overview
- 8.10.3 Shanghai Haoyuan Chemexpress Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Shanghai Haoyuan Chemexpress Quetiapine Product Portfolio
- 8.10.5 Shanghai Haoyuan Chemexpress Recent Developments
- 8.11 Dr. Reddy's
- 8.11.1 Dr. Reddy's Company Information
- 8.11.2 Dr. Reddy's Business Overview
- 8.11.3 Dr. Reddy's Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Dr. Reddy's Quetiapine Product Portfolio
- 8.11.5 Dr. Reddy's Recent Developments
- 8.12 Aurobindo
- 8.12.1 Aurobindo Company Information
- 8.12.2 Aurobindo Business Overview
- 8.12.3 Aurobindo Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Aurobindo Quetiapine Product Portfolio
- 8.12.5 Aurobindo Recent Developments
- 8.13 AstraZeneca
- 8.13.1 AstraZeneca Company Information
- 8.13.2 AstraZeneca Business Overview
- 8.13.3 AstraZeneca Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 AstraZeneca Quetiapine Product Portfolio
- 8.13.5 AstraZeneca Recent Developments
- 8.14 Wuhan Fortuna Chemical
- 8.14.1 Wuhan Fortuna Chemical Company Information
- 8.14.2 Wuhan Fortuna Chemical Business Overview
- 8.14.3 Wuhan Fortuna Chemical Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Wuhan Fortuna Chemical Quetiapine Product Portfolio
- 8.14.5 Wuhan Fortuna Chemical Recent Developments
- 8.15 Waterstone Technology
- 8.15.1 Waterstone Technology Company Information
- 8.15.2 Waterstone Technology Business Overview
- 8.15.3 Waterstone Technology Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Waterstone Technology Quetiapine Product Portfolio
- 8.15.5 Waterstone Technology Recent Developments
- 8.16 Toronto Research Chemicals
- 8.16.1 Toronto Research Chemicals Company Information
- 8.16.2 Toronto Research Chemicals Business Overview
- 8.16.3 Toronto Research Chemicals Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Toronto Research Chemicals Quetiapine Product Portfolio
- 8.16.5 Toronto Research Chemicals Recent Developments
- 8.17 Nanjing Chemlin Chemical
- 8.17.1 Nanjing Chemlin Chemical Company Information
- 8.17.2 Nanjing Chemlin Chemical Business Overview
- 8.17.3 Nanjing Chemlin Chemical Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Nanjing Chemlin Chemical Quetiapine Product Portfolio
- 8.17.5 Nanjing Chemlin Chemical Recent Developments
- 8.18 EMMX Biotechnology
- 8.18.1 EMMX Biotechnology Company Information
- 8.18.2 EMMX Biotechnology Business Overview
- 8.18.3 EMMX Biotechnology Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.18.4 EMMX Biotechnology Quetiapine Product Portfolio
- 8.18.5 EMMX Biotechnology Recent Developments
- 8.19 BOC Sciences
- 8.19.1 BOC Sciences Company Information
- 8.19.2 BOC Sciences Business Overview
- 8.19.3 BOC Sciences Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.19.4 BOC Sciences Quetiapine Product Portfolio
- 8.19.5 BOC Sciences Recent Developments
- 8.20 AlliChem
- 8.20.1 AlliChem Company Information
- 8.20.2 AlliChem Business Overview
- 8.20.3 AlliChem Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.20.4 AlliChem Quetiapine Product Portfolio
- 8.20.5 AlliChem Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Quetiapine Value Chain Analysis
- 9.1.1 Quetiapine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Quetiapine Production Mode & Process
- 9.2 Quetiapine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Quetiapine Distributors
- 9.2.3 Quetiapine Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst